Cellarity Is A Biotechnology Company Founded In 2017 By Flagship Pioneeringit Focuses On A Novel Approach To Drug Discovery That Targets Cellular Behavior Instead Of Individual Molecular Targetsthe Company Aims To Transform Medicine Creation By Addressing The Complexity Of Diseases Through A Platform That Integrates Single Cell Technologiesmachine Learningand Computational Biology The Core Technology Of Cellarity Includes Single Cell Analysiswhich Quantifies Cellular Behaviors And Defines The Molecular Networks Driving Diseasemachine Learning Is Used To Model Cellular Dynamics And Predict Drug Candidates That Can Restore Healthy Cell Behaviorthe Company Generates Medicines By Targeting Interconnected Networks That Govern Cell Behaviorallowing For Discovery Across Various Disease Areasincluding Metabolic Diseasehematologyimmuno Oncologyand Respiratory Diseasecellarity S Innovative Approach Enhances The Success Rates Of Drug Discovery And Positions It As A Leader In Next Generation Therapeutics
